Metrics to compare | 4737 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4737PeersSector | |
|---|---|---|---|---|
P/E Ratio | −17.1x | 37.0x | −0.5x | |
PEG Ratio | 0.22 | −0.37 | 0.00 | |
Price/Book | 1.9x | 2.4x | 2.6x | |
Price / LTM Sales | 2.4x | 2.5x | 3.0x | |
Upside (Analyst Target) | - | 46.5% | 58.6% | |
Fair Value Upside | Unlock | 21.5% | 10.2% | Unlock |
Bionime Corporation designs, manufactures, and sells medical instruments in China, Switzerland, the United States, Belarus, Algeria, the United Arab Emirates, Egypt, and internationally. The company manufactures and sells blood glucose meters and test strips to medical equipment companies, pharmacies, and hospitals, as well as offering blood glucose monitoring devices and systems under the RIGHTEST brand; a continuous glucose monitoring system under the iFree CGM brand; and medical blood glucose management systems. It is also involved in the provision of biotechnology services; drug testing; examination of pharmaceutical products; and the sale of precision instruments. The company also provides wholesale medical devices, biotechnology services, pharmaceutical testing, and wholesale of precision instruments. Bionime Corporation was incorporated in 2003 and is based in Taichung, Taiwan.